Stay updated on Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.0%
    Check dated 2024-06-13T22:42:42.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 on the webpage has recently changed to 8. This change represents an update in the study record details of a Phase 3 clinical trial evaluating Pembrolizumab versus placebo as adjuvant therapy for participants with high-risk locally advanced cutaneous squamous cell carcinoma.
    Difference
    0.0%
    Check dated 2024-06-06T14:29:01.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying requirements such as confirmed cutaneous squamous cell carcinoma, completion of adjuvant radiotherapy, and other health conditions. Previously, this section only indicated that no information was provided.
    Difference
    17%
    Check dated 2024-05-22T20:53:34.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2024-04-30T22:15:25.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page.